國立虎尾科技大學 |

Orthobiologics = Injectable Therapies for the Musculoskeletal System /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Orthobiologics/ edited by Giuseppe Filardo, Bert R. Mandelbaum, George F. Muschler, Scott A. Rodeo, Norimasa Nakamura.
其他題名:	Injectable Therapies for the Musculoskeletal System /
其他作者:	Nakamura, Norimasa.
面頁冊數:	XI, 402 p. 73 illus., 66 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Health Sciences. -
電子資源:	https://doi.org/10.1007/978-3-030-84744-9
ISBN:	9783030847449

Orthobiologics = Injectable Therapies for the Musculoskeletal System /
OrthobiologicsInjectable Therapies for the Musculoskeletal System /[electronic resource] :edited by Giuseppe Filardo, Bert R. Mandelbaum, George F. Muschler, Scott A. Rodeo, Norimasa Nakamura. - 1st ed. 2022. - XI, 402 p. 73 illus., 66 illus. in color.online resource.

I. Injectable OrthoBiologics: Formulations and Rationale 1. Bone marrow-derived cultured stromal cells and Bone Marrow Concentrate -- 2. Adipose-derived cultured stromal cells and Stromal Vascular Fraction from adipose tissue -- 3. Synovial-derived cultured stromal cells -- 4. Amniotic, Placenta, and Umbilical cord-derived cultured stromal cells -- 5. Allogeneic cells: pros and cons -- 6. Steroid hormones -- 7. Cytokines, chemokines, alpha-2-macroglobulin, growth factors -- 8. Platelet-rich plasma: leucocyte-rich, leukocyte-poor, autologous conditioned serum, autologous protein solution -- 9. Amniotic tissue extract, placenta tissue extract -- 10. Extracellular vesicles (exosomes) -- II. Injectable OrthoBiolologics: evaluation methods and results based on pathology and anatomy -- 11. Rotator cuff tendinopathy: cell therapy -- 12. Rotator cuff tendinopathy: biologics -- 13. Tennis elbow: cell therapy -- 14. Tennis elbow: cell therapy biologics -- 15. Patellar tendinopathy: cell therapy -- 16. Patellar tendinopathy: biologics -- 17. Achilles tendinopathy: cell therapy -- 18. Achilles tendinopathy: biologics -- 19. Plantar Fasciitis: cell therapy -- 20. Plantar Fasciitis: biologics -- 21. Ligament lesions: cell therapy -- 22. Ligament lesions: biologics -- 23. Meniscal lesions: cell therapy -- 24. Meniscal lesions: biologics -- 25. Muscle lesions: cell therapy -- 26. Muscle lesions: biologics -- 27. Fractures (incl. Nonunions): cell therapy -- 28. Fractures (incl. Nonunions): biologics -- 29. Cartilage lesions and Osteoarthritis of the knee: cell therapy -- 30. Cartilage lesions and Osteoarthritis of the knee: biologics -- 31. Cartilage lesions and Osteoarthritis of the hip and ankle: cell therapy -- 32. Cartilage lesions and Osteoarthritis of the hip and ankle: biologics -- III. Future directions 33. Pluripotent stem cells: Embryonic/Fetal stem cells and induced pluripotent stem (iPS) cells -- 34. Gene therapy -- 35. Stimulation of the intrinsic stromal cell niche -- 36 Conclusions.

This book presents the evidence related to the use of injectable biologics to provide faster and better healing for musculoskeletal lesions and conditions. The authors discuss approaches, such as blood derivatives and cell concentrates, applied to lesions of muscles, ligaments, tendons, bones, meniscus and cartilage, as well as osteoarthritis. Chapters are written by some of the most influential opinion leaders in the field, with up-to-date review of the current literature, where the authors explore both the potential and the limitations of these minimally invasive and promising treatments. The first section is devoted to the formulations and rationale for the use of injectable orthobiologics, while the second section reviews current treatment methods applied to specific joints and pathologies – ranging from tendinopathies through non-unions to articular degenerative processes – as well as the results of these treatment approaches. The third section explores future perspectives, such as pluripotent stem cells, gene therapy, and the stimulation of intrinsic stromal cell niches. Appealing to a broad readership, this book will be of interest to both laboratory research scientists and clinicians, including orthopedists, sports physicians, physiatrists, and regenerative medicine experts.

ISBN: 9783030847449

Standard No.: 10.1007/978-3-030-84744-9doiSubjects--Topical Terms:

1365910
Health Sciences.

LC Class. No.: RD701-811

Dewey Class. No.: 616.7

Orthobiologics = Injectable Therapies for the Musculoskeletal System /
LDR:04745nam a22003975i 4500 001 1091423
003 DE-He213
005 20220116035426.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783030847449 $9 978-3-030-84744-9
024 7 $a 10.1007/978-3-030-84744-9 $2 doi
035 $a 978-3-030-84744-9
050 4 $a RD701-811
072 7 $a MNS $2 bicssc
072 7 $a MED065000 $2 bisacsh
072 7 $a MNS $2 thema
082 0 4 $a 616.7 $2 23
245 1 0 $a Orthobiologics $h [electronic resource] : $b Injectable Therapies for the Musculoskeletal System / $c edited by Giuseppe Filardo, Bert R. Mandelbaum, George F. Muschler, Scott A. Rodeo, Norimasa Nakamura.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a XI, 402 p. 73 illus., 66 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a I. Injectable OrthoBiologics: Formulations and Rationale 1. Bone marrow-derived cultured stromal cells and Bone Marrow Concentrate -- 2. Adipose-derived cultured stromal cells and Stromal Vascular Fraction from adipose tissue -- 3. Synovial-derived cultured stromal cells -- 4. Amniotic, Placenta, and Umbilical cord-derived cultured stromal cells -- 5. Allogeneic cells: pros and cons -- 6. Steroid hormones -- 7. Cytokines, chemokines, alpha-2-macroglobulin, growth factors -- 8. Platelet-rich plasma: leucocyte-rich, leukocyte-poor, autologous conditioned serum, autologous protein solution -- 9. Amniotic tissue extract, placenta tissue extract -- 10. Extracellular vesicles (exosomes) -- II. Injectable OrthoBiolologics: evaluation methods and results based on pathology and anatomy -- 11. Rotator cuff tendinopathy: cell therapy -- 12. Rotator cuff tendinopathy: biologics -- 13. Tennis elbow: cell therapy -- 14. Tennis elbow: cell therapy biologics -- 15. Patellar tendinopathy: cell therapy -- 16. Patellar tendinopathy: biologics -- 17. Achilles tendinopathy: cell therapy -- 18. Achilles tendinopathy: biologics -- 19. Plantar Fasciitis: cell therapy -- 20. Plantar Fasciitis: biologics -- 21. Ligament lesions: cell therapy -- 22. Ligament lesions: biologics -- 23. Meniscal lesions: cell therapy -- 24. Meniscal lesions: biologics -- 25. Muscle lesions: cell therapy -- 26. Muscle lesions: biologics -- 27. Fractures (incl. Nonunions): cell therapy -- 28. Fractures (incl. Nonunions): biologics -- 29. Cartilage lesions and Osteoarthritis of the knee: cell therapy -- 30. Cartilage lesions and Osteoarthritis of the knee: biologics -- 31. Cartilage lesions and Osteoarthritis of the hip and ankle: cell therapy -- 32. Cartilage lesions and Osteoarthritis of the hip and ankle: biologics -- III. Future directions 33. Pluripotent stem cells: Embryonic/Fetal stem cells and induced pluripotent stem (iPS) cells -- 34. Gene therapy -- 35. Stimulation of the intrinsic stromal cell niche -- 36 Conclusions.
520 $a This book presents the evidence related to the use of injectable biologics to provide faster and better healing for musculoskeletal lesions and conditions. The authors discuss approaches, such as blood derivatives and cell concentrates, applied to lesions of muscles, ligaments, tendons, bones, meniscus and cartilage, as well as osteoarthritis. Chapters are written by some of the most influential opinion leaders in the field, with up-to-date review of the current literature, where the authors explore both the potential and the limitations of these minimally invasive and promising treatments. The first section is devoted to the formulations and rationale for the use of injectable orthobiologics, while the second section reviews current treatment methods applied to specific joints and pathologies – ranging from tendinopathies through non-unions to articular degenerative processes – as well as the results of these treatment approaches. The third section explores future perspectives, such as pluripotent stem cells, gene therapy, and the stimulation of intrinsic stromal cell niches. Appealing to a broad readership, this book will be of interest to both laboratory research scientists and clinicians, including orthopedists, sports physicians, physiatrists, and regenerative medicine experts.
650 2 4 $a Health Sciences. $3 1365910
650 2 4 $a Regenerative Medicine and Tissue Engineering. $3 1366894
650 2 4 $a Sports Medicine. $3 583901
650 1 4 $a Orthopaedics. $3 1366677
650 0 $a Medical sciences. $3 1208799
650 0 $a Regenerative medicine. $3 782729
650 0 $a Sports medicine. $3 644040
650 0 $a Orthopedics. $3 596623
700 1 $a Nakamura, Norimasa. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1140540
700 1 $a Rodeo, Scott A. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1399009
700 1 $a Muschler, George F. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1399008
700 1 $a Mandelbaum, Bert R. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 683065
700 1 $a Filardo, Giuseppe. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1399007
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030847432
776 0 8 $i Printed edition: $z 9783030847456
776 0 8 $i Printed edition: $z 9783030847463
856 4 0 $u https://doi.org/10.1007/978-3-030-84744-9
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)